Browsing Category

24318 posts

Vantage Enhances Its V-Card Premium Payment Experience for CFD Traders

V-Card combines everyday spending, applicable transaction fees and convenient card management. PORT…

Zai Lab's Zocilurtatug Pelitecan (Zoci, Formerly ZL-1310) Demonstrates High Response Rates, Encouraging Durability and Well-Tolerated Safety Profile in First-Line Extensive-Stage Small Cell Lung Cancer

–  At the recommended Phase 3 dose (RP3D) of 1.6 mg/kg, zoci…

Coreline Soft Receives U.S. FDA 510(k) Clearance for AVIEW Aorta Metrics, Expanding Its Chest CT AI Portfolio in the U.S.

Secures its 13th FDA 510(k) clearance, expanding its U.S. portfolio from lung…

2026 ESMO LBA | Innovent Announces International Phase 3 Study of Arcotatug Tavatecan (CLDN18.2-ADC) in Gastric Cancer Met Dual Primary Endpoints of PFS and OS

Registrational Phase 3 G-HOPE-001 Study Met Both Primary Endpoints, Demonstrating Statistically Significant…
India's Spiritual Leadership Takes Center Stage Globally: *H.H. Shree Shivkrupanand Swami, promoter of global spritual platform 'Gurutattva' and 'Himalayan Samarpan Meditation', appointed Vice Chair of 'World Meditation Day Governance Committee'

India's Spiritual Leadership Takes Center Stage Globally: *H.H. Shree Shivkrupanand Swami, promoter of global spritual platform 'Gurutattva' and 'Himalayan Samarpan Meditation', appointed Vice Chair of 'World Meditation Day Governance Committee'

NEW DELHI, Oct. 23, 2026 /PRNewswire/ — In a historic milestone marking India’s…
New Prize Pool Unlocked: Bybit Extends USD1 Hold & Earn Program With 27 Million WLFI in Rewards

New Prize Pool Unlocked: Bybit Extends USD1 Hold & Earn Program With 27 Million WLFI in Rewards

DUBAI, UAE, Oct. 23, 2026 /PRNewswire/ — Bybit, the New Financial Platform trusted…
Taishin International Bank Opens Flagship Private Banking Branch in Southern Taiwan

Taishin International Bank Opens Flagship Private Banking Branch in Southern Taiwan

Strategic alliance with Switzerland’s UBP brings global investment expertise and international wealth…

Alebund Pharmaceuticals Announces Poster Presentation by Partner R1 Therapeutics of Global Phase IIb Multi-Regional Clinical Trial Design for AP306 at ASN Kidney Week 2026

SHANGHAI, Oct. 23, 2026 /PRNewswire/ — Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or…